71 related articles for article (PubMed ID: 22730093)
21. Tumour necrosis as assessed with
Kahle XU; Hovingh M; Noordzij W; Seitz A; Diepstra A; Visser L; van den Berg A; van Meerten T; Huls G; Boellaard R; Kwee TC; Nijland M
Eur Radiol; 2019 Nov; 29(11):6018-6028. PubMed ID: 31028445
[TBL] [Abstract][Full Text] [Related]
22. Prognostic analysis of interim
Yuan L; Kreissl MC; Su L; Wu Z; Hacker M; Liu J; Zhang X; Bo Y; Zhang H; Li X; Li S
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):478-488. PubMed ID: 30382301
[TBL] [Abstract][Full Text] [Related]
23. Metabolic tumor volume changes assessed by interval
Oñate-Ocaña LF; Cortés V; Castillo-Llanos R; Terrazas A; Garcia-Perez O; Pitalúa-Cortes Q; Ponce M; Dueñas-Gonzalez A; Candelaria M
Oncol Lett; 2018 Aug; 16(2):1411-1418. PubMed ID: 30008818
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation.
Park YS; Lee SM; Park JS; Bae SK; Shim HK; Lee WS; Lee SM
Nucl Med Mol Imaging; 2018 Jun; 52(3):216-223. PubMed ID: 29942400
[TBL] [Abstract][Full Text] [Related]
25. Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients.
Wang L; Wang JH; Bi XW; Chen XQ; Lu Y; Xia ZJ
Oncotarget; 2017 Nov; 8(58):99104-99111. PubMed ID: 29228756
[TBL] [Abstract][Full Text] [Related]
26. Detection of non-Hodgkin lymphoma by [¹⁸F]FDG-PET/CT in a patient with differentiated thyroid cancer.
Guidoccio F; Grosso M; Antonelli A
Endocrine; 2015 Sep; 50(1):260-1. PubMed ID: 25480655
[No Abstract] [Full Text] [Related]
27. Prognostic Value of Metabolic Tumor Volume Estimated by (18) F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III Disease.
Kim J; Hong J; Kim SG; Hwang KH; Kim M; Ahn HK; Sym SJ; Park J; Cho EK; Shin DB; Lee JH
Nucl Med Mol Imaging; 2014 Sep; 48(3):187-95. PubMed ID: 25177375
[TBL] [Abstract][Full Text] [Related]
28. Metabolic burden measured by (18)f-fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in patients with small cell lung cancer.
Kim MH; Lee JS; Mok JH; Lee K; Kim KU; Park HK; Kim SJ; Lee MK
Cancer Res Treat; 2014 Apr; 46(2):165-71. PubMed ID: 24851108
[TBL] [Abstract][Full Text] [Related]
29. Correlations between functional imaging markers derived from PET/CT and diffusion-weighted MRI in diffuse large B-cell lymphoma and follicular lymphoma.
Wu X; Pertovaara H; Korkola P; Dastidar P; Järvenpää R; Eskola H; Kellokumpu-Lehtinen PL
PLoS One; 2014; 9(1):e84999. PubMed ID: 24454777
[TBL] [Abstract][Full Text] [Related]
30. Multiple recurrent extra-medullary relapses of high-grade diffuse large B-cell lymphoma presenting in acute leukemic phase.
Jain P; Sargent RL; Konoplev SN; Benjamini O; Kantarjian H; Kadia T
Am J Hematol; 2013 May; 88(5):433-4. PubMed ID: 23460270
[No Abstract] [Full Text] [Related]
31. Prognostic value of interim FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: Systematic review and meta-analysis.
Adams HJ; Kwee TC
Crit Rev Oncol Hematol; 2016 Oct; 106():55-63. PubMed ID: 27637352
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of interim PET/CT in DLBCL treated with R-CHOP: meta-analysis.
Sun N; Zhao J; Qiao W; Wang T
Biomed Res Int; 2015; 2015():648572. PubMed ID: 25710013
[TBL] [Abstract][Full Text] [Related]
33. The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma.
Park S; Moon SH; Park LC; Hwang DW; Ji JH; Maeng CH; Cho SH; Ahn HK; Lee JY; Kim SJ; Choi JY; Kim WS
Am J Hematol; 2012 Sep; 87(9):937-40. PubMed ID: 22730093
[TBL] [Abstract][Full Text] [Related]
34. Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma.
Wu X; Pertovaara H; Korkola P; Vornanen M; Järvenpää R; Dastidar P; Eskola H; Kellokumpu-Lehtinen PL
Acta Oncol; 2014 Aug; 53(8):1093-9. PubMed ID: 24960581
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
Yang DH; Min JJ; Song HC; Jeong YY; Chung WK; Bae SY; Ahn JS; Kim YK; Bom HS; Chung IJ; Kim HJ; Lee JJ
Eur J Cancer; 2011 Jun; 47(9):1312-8. PubMed ID: 21334197
[TBL] [Abstract][Full Text] [Related]
36. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
